BANK VONTOBEL/CALL/PFIZER INC/31/0.1/20.09.24 Stock

Warrant

DE000VM31BE1

Market Closed - Deutsche Boerse AG 14:03:04 2024-06-27 EDT
0.034 EUR +25.93% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/31/0.1/20.09.24
Current month-49.25%
1 month-61.36%
Date Price Change
24-06-27 0.034 +25.93%
24-06-26 0.027 -25.00%
24-06-25 0.036 +2.86%
24-06-24 0.035 +9.38%
24-06-21 0.032 -13.51%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 02:03 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM31BE
ISINDE000VM31BE1
Date issued 2023-10-16
Strike 31 $
Maturity 2024-09-20 (85 Days)
Parity 10 : 1
Emission price 0.33
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.46
Lowest since issue 0.024
Delta0.22x
Omega 13.87
Premium13.09x
Gearing63.34x
Moneyness 0.8968
Difference Strike 3.2 $
Difference Strike %+10.32%
Spread 0.01
Spread %21.74%
Intrinsic value 0.000000

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.8 USD
Average target price
31.92 USD
Spread / Average Target
+14.80%
Consensus